Epinephrine IV Bags Recalled Due to Lack of Sanitization Validation
Central Admixture Pharmacy Services is recalling epinephrine IV bags (Lot 36-260047) because sanitization processes lacked adequate validation data. The manufacturer cannot confirm the product meets sterility standards required for injectable medications.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall concerns an injectable medication with a sterility assurance defect. While no illnesses or injuries are reported in the source, it involves a risk-of-harm product where potential contamination has not yet resulted in documented patient harm, meeting the rubric criterion for High severity.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 292 bags of epinephrine IV solution (4 mg/250 mL in 0.9% sodium chloride). The affected lot is 36-260047 with an expiration date of October 3, 2023. Distribution was nationwide in the United States.
The FDA issued a Class II recall due to lack of assurance of sterility. The manufacturer did not have adequate validation data to demonstrate that its sanitization cycles were effective. This validation gap creates uncertainty about whether the product meets sterility requirements for injectable medications.
Epinephrine is administered intravenously in emergency and acute care settings. The unvalidated sanitization processes could result in inadequate sterility assurance for this critical medication.
The recalled product
- Product
- EPINEPHrine added to 0.9% sodium chloride, 4mg/250mL (16 mcg/mL), IV Bag, RX only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-8093-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Hazard
- contamination-risk
- sterility-assurance-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 36-260047
- Exp 10/3/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27